Literature DB >> 3912316

Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations.

E H Weiss, W Kuon, C Dörner, M Lang, G Riethmüller.   

Abstract

Among the numerous autoimmune diseases associated with various HLA alleles, the one with the highest relative risk so far reported has been ankylosing spondylitis with HLA-B27. To examine this relationship more directly, we have cloned the gene encoding the HLA-B27 antigen and determined its complete DNA sequence. Comparison of the HLA-B27 sequence with that of the allelic HLA-B27 shows a high level of homology. Mutations are distributed evenly between exons and introns. Exon 1 and intron 1 are the most divergent ones, and the degree of divergence distinctly declines towards the 3' end. The HLA-B57 gene when transfected into murine L cells is expressed on the cell surface and reacts with a panel of monoclonal antibodies directed against monomorphic and polymorphic determinants associated with HLA-B27 antigen. The isolation of this gene allows for the first time a search for structural features which make the HLA-B27 antigen a high risk genetic factor for a group of rheumatoid disorders, in particular ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3912316     DOI: 10.1016/S0171-2985(85)80061-9

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  26 in total

1.  Recycling MHC class I molecules and endosomal peptide loading.

Authors:  M Grommé; F G Uytdehaag; H Janssen; J Calafat; R S van Binnendijk; M J Kenter; A Tulp; D Verwoerd; J Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues.

Authors:  A Dey; A M Thornton; M Lonergan; S M Weissman; J W Chamberlain; K Ozato
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

3.  Differential regulation of HLA class I genes by interferon.

Authors:  H Schmidt; V Gekeler; H Haas; G Engler-Blum; I Steiert; H Probst; C A Müller
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Molecular typing of HLA-B27 alleles.

Authors:  O Dominguez; E Coto; E Martinez-Naves; S Y Choo; C López-Larrea
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  An HLA-B regulatory element binds a factor immunologically related to the upstream stimulation factor.

Authors:  J Girdlestone
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Use of RecA protein to enrich for homologous genes in a genomic library.

Authors:  B Taidi-Laskowski; D Tyan; S M Honigberg; C R Radding; F C Grumet
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

7.  Cloning and genomic characterization of LST1: a new gene in the human TNF region.

Authors:  I Holzinger; A de Baey; G Messer; G Kick; H Zwierzina; E H Weiss
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  A subset of HLA-B27 molecules contains peptides much longer than nonamers.

Authors:  R G Urban; R M Chicz; W S Lane; J L Strominger; A Rehm; M J Kenter; F G UytdeHaag; H Ploegh; B Uchanska-Ziegler; A Ziegler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.

Authors:  L T Peltenburg; P I Schrier
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.

Authors:  C M Higgins; T Lund; M E Shipley; A Ebringer; M Sadowska-Wroblewska; R K Craig
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.